Subscribe To
Prophase labs’ linebacker-1 cancer therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including l
Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagno...
May 3, 2023, 12:30 pm
Can-fite biopharma spikes on pancreatic cancer inhibition finding
Can-Fite BioPharma Ltd. NYSEAMERICAN: CANF is an Israel-based biotechnology firm that develops small-mole...
May 2, 2023, 1:12 pm
Ten63 therapeutics raises $15.9 million in oversubscribed series a financing to drug the undruggables by combining the power of ai and physics-based models
Ten63’s foundation is built on research developed by world-renowned computational scientists at Duke University Proprietary BEYOND platform searches...
May 2, 2023, 11:30 am
Opgen announces pricing of $3.5 million public offering
ROCKVILLE, Md., May 01, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessin...
May 2, 2023, 1:00 am
Predicine to introduce predicinealert™ mrd assay and present two ctdna studies in genitourinary cancers at aua 2023 annual meeting
HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) — Predicine, a global molecular insights company, an...
April 28, 2023, 9:42 pm
The starch sugar enzymes market are projected to reach usd 6.20 billion by 2030, from usd 3.62 billion in 2022,registering a cagr of 6.50% during the forecast period 2023-2030| data by contrive datum
According to a market research study published by Contrive Datum Insights, Starch/sugar enzymes occur in a variety of microorganisms and are used to a...
April 28, 2023, 2:28 pm
Tavros therapeutics and openbench expand strategic collaboration for small molecule drug discovery
Multi-target collaboration leverages Tavros’ proprietary functional genomic discovery program and OpenBench’s screening platform Partnership strea...
April 27, 2023, 12:19 pm
Immunic inc announces appointment of dr richard rudick to board of directors
Immunic Inc (NASDAQ:IMUX) has announced the appointment of Dr Richard Rudick to its board of directors, effective April 26, 2023. The biotechnology c...
April 27, 2023, 8:32 am
Kalvista pharmaceuticals to present data at the 13th c1-inhibitor deficiency & angioedema workshop
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
April 27, 2023, 6:30 am
60 degrees pharmaceuticals awarded u.s. patent covering tafenoquine for treatment of covid-19 and other lung infections
Patent provides exclusive use through 2040 of tafenoquine for treatment of COVID-19 and other lung infections. Tafenoquine is the active ...
April 26, 2023, 11:34 am
X4 pharmaceuticals to report first-quarter 2023 financial results and host a conference call and webcast on may 4, 2023
BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small ...
April 26, 2023, 8:01 am
Betterlife to present betr-001 preclinical data at the 2023 annual meeting of the society of biological psychiatry (sobp) in san diego, california
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BE...
April 25, 2023, 8:00 am
Ideaya biosciences shares jump on melanoma interim trial results
IDEAYA Biosciences shares jumped after the company posted additional positive interim results from its Phase 2 clinical trial evaluating its darovaser...
April 24, 2023, 12:27 pm
molecular partners: sellers have disappeared, enterprise value below zero
molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero....
April 20, 2023, 2:08 am
Cognition therapeutics to present analysis showing impact of ct1812 on pathways implicated in dry age-related macular degeneration at arvo 2023
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be presenting in vitro results characterizing the role ...
April 19, 2023, 11:30 am
The global digital breast tomosynthesis (dbt) system market size is expected to grow from usd us$ 8.1 billion in 2023 to 2030. at a cagr of 14.2% during forecast period 2023 to 2030 | data by contrive
According to a market research study published by Contrive Datum Insights, Liquid biopsy is a non-invasive diagnostic tool that involves the analysis ...
April 18, 2023, 12:38 am
The global digital breast tomosynthesis (dbt) system market size is expected to grow from usd us$ 8.1 billion in 2023 to 2030. at a cagr of 14.2% during forecast period 2023 to 2030 | data by contrive
According to a market research study published by Contrive Datum Insights, Liquid biopsy is a non-invasive diagnostic tool that involves the analysis ...
April 18, 2023, 12:38 am
Biocept outlines plans to get cnside assay system commercially available, looks back on the 2022 financial year
Biocept Inc (NASDAQ:BIOC), which develops and commercializes molecular diagnostic assays, revealed new ...
April 17, 2023, 4:47 pm
Diacarta announces five abstracts accepted for presentation at aacr annual meeting 2023
Abstracts demonstrating XNA technology’s improvements to assay sensitivity across different technology platforms and support for use in companion di...
April 16, 2023, 6:00 pm
Quanta therapeutics presents data from kras inhibitor pipeline at annual aacr meeting in late-breaking research session
– Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small mole...
April 14, 2023, 4:05 pm